Poor responding gynecologic cancers get boost from genomic profiling
Research examining gynecologic cancers that poorly respond to therapy shows genomic profiling can help identify alternate and targeted treatments, report scientists.
Research examining gynecologic cancers that poorly respond to therapy shows genomic profiling can help identify alternate and targeted treatments, report scientists.
Leave a Reply